MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which took place on May 21, 2026, in Marseille. All resolutions were voted. A total of 94 votes were cast out of a total of 34,872,293 … [Read more…]
SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced changes to its senior leadership team aimed at strengthening operational performance and efficiency. As part of these changes, the Board has made the decision that Josh Smiley, President and COO, will no longer be with the Company, effective Friday, May 22. “I … [Read more…]
SAN FRANCISCO–(BUSINESS WIRE)–Oura Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet … [Read more…]
The framework goes beyond binary review of answers to assess context, uncertainty, and clinical impact; designed to support governance committees WALTHAM, Mass.–(BUSINESS WIRE)–#ai—Wolters Kluwer Health today released its approach to validating and evaluating clinical AI that is designed to reflect how clinicians use and rely on AI at the point of care. Designed to help … [Read more…]
Reports Strong Revenue, Gross Margin, and Income Growth Details Exciting Progress on Contamination Prevention Category Creation MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and … [Read more…]
– The disease remains a public health challenge with an estimated 50,000 to 90,000 new cases each year – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced a renewed five-year collaboration with the World Health Organization (WHO), committing funding, strategic support and product donations to accelerate progress toward eliminating visceral leishmaniasis (VL), also … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#BofA–American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today the pricing of an underwritten public offering of 14,000,000 shares of its common stock, all of which are being offered in connection with the forward sale agreement described below. The aggregate gross proceeds to the Company from the offering, before deducting estimated offering … [Read more…]
Showcase Presentation at AUA 2026 Innovation Nexus Ignites Excitement Around a New Era in Stone Management SAN FRANCISCO–(BUSINESS WIRE)–Avvio Medical, a clinical-stage medical device company developing Microbubble SonoLithotripsy for the treatment of ureteral stones, reports today on its successful conference at the 2026 American Urological Association (AUA) Annual Meeting, held May 15-18 in Washington, DC. … [Read more…]
– Data demonstrate mRNA delivery, protein expression and activity in the airways of PCD patients – – Abstract selected for oral presentation at 2026 American Thoracic Society International Conference – MENLO PARK, Calif.–(BUSINESS WIRE)–ReCode Therapeutics, a clinical-stage genetic medicines company using lipid nanoparticle delivery to power the next wave of mRNA and gene correction therapeutics, … [Read more…]
Strategic acquisition strengthens InSphero’s global position as the market leader in predictive in vitro modeling and high-content imaging services SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–#Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of … [Read more…]
